Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106907

Lysozyme turnover in man

Niels Ebbe Hansen, Hans Karle, Vagn Andersen, and Klaus Ølgaard

Division of Hematology, Department of Medicine A, Department of Medicine TA, University Hospital of Copenhagen, Blegdamsvej, DK 2100, Denmark

Division of Nephrology, Department of Medicine P, Rigshospitalet, University Hospital of Copenhagen, Blegdamsvej, DK 2100, Denmark

Find articles by Hansen, N. in: PubMed | Google Scholar

Division of Hematology, Department of Medicine A, Department of Medicine TA, University Hospital of Copenhagen, Blegdamsvej, DK 2100, Denmark

Division of Nephrology, Department of Medicine P, Rigshospitalet, University Hospital of Copenhagen, Blegdamsvej, DK 2100, Denmark

Find articles by Karle, H. in: PubMed | Google Scholar

Division of Hematology, Department of Medicine A, Department of Medicine TA, University Hospital of Copenhagen, Blegdamsvej, DK 2100, Denmark

Division of Nephrology, Department of Medicine P, Rigshospitalet, University Hospital of Copenhagen, Blegdamsvej, DK 2100, Denmark

Find articles by Andersen, V. in: PubMed | Google Scholar

Division of Hematology, Department of Medicine A, Department of Medicine TA, University Hospital of Copenhagen, Blegdamsvej, DK 2100, Denmark

Division of Nephrology, Department of Medicine P, Rigshospitalet, University Hospital of Copenhagen, Blegdamsvej, DK 2100, Denmark

Find articles by Ølgaard, K. in: PubMed | Google Scholar

Published May 1, 1972 - More info

Published in Volume 51, Issue 5 on May 1, 1972
J Clin Invest. 1972;51(5):1146–1155. https://doi.org/10.1172/JCI106907.
© 1972 The American Society for Clinical Investigation
Published May 1, 1972 - Version history
View PDF
Abstract

Lysozyme turnover studies with 125I-labeled human lysozyme were carried out on 22 patients, viz. nine control patients, seven nephrological patients with varying degrees of renal insufficiency, including three bilaterally nephrectomized patients, and six hematological patients with disturbed turnover of the neutrophilic granulocytes.

It was found that plasma lysozyme has a rapid turnover with a fractional catabolic rate of 76%/hr of the plasma content. Lysozyme catabolism varied with the endogenous creatinine clearance; in addition however, extrarenal sites of catabolism were demonstrated since lysozyme could be broken down in the anephric patients, although only at a rate amounting to about 15% of the rate found in persons with intact kidneys. In the uremic patients the increased plasma lysozyme concentration was due to decreased rates of catabolism; in the hematological patients the increased plasma lysozyme level was due to increased rates of synthesis which supports the hypothesis that plasma lysozyme mainly stems from disintegrating neutrophilic granulocytes. Furthermore, it was shown that in the nonhematological patients examined, the rate of synthesis varied with the endogenous creatinine clearance.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1146
page 1146
icon of scanned page 1147
page 1147
icon of scanned page 1148
page 1148
icon of scanned page 1149
page 1149
icon of scanned page 1150
page 1150
icon of scanned page 1151
page 1151
icon of scanned page 1152
page 1152
icon of scanned page 1153
page 1153
icon of scanned page 1154
page 1154
icon of scanned page 1155
page 1155
Version history
  • Version 1 (May 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts